Gallium-68-DOTA-NOC PET/CT of Patients With Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Single-Center Study

2011 ◽  
Vol 197 (5) ◽  
pp. 1221-1228 ◽  
Author(s):  
Niraj Naswa ◽  
Punit Sharma ◽  
Abhishek Kumar ◽  
Aftab Hasan Nazar ◽  
Rakesh Kumar ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Single Center ◽  
Gastroenteropancreatic Neuroendocrine Tumors ◽  
Pet Ct ◽  
Single Center Study ◽  
Gallium 68 ◽  
Center Study

ENDOSCOPIC TREATMENT OF RECTAL NEUROENDOCRINE TUMORS IN A 12 YEAR RETROSPECTIVE SINGLE CENTER STUDY

2019 ◽  
Author(s):  
K Dąbkowski ◽  
A Białek ◽  
N Rusiniak-Rossińska ◽  
K Michalska ◽  
B Kos-Kudła ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Endoscopic Treatment ◽  
Single Center ◽  
Single Center Study ◽  
Center Study

Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study

2017 ◽  
Vol 32 (1) ◽  
pp. 443-449 ◽  
Author(s):  
Sang Hyup Han ◽  
In Woong Han ◽  
Jin Seok Heo ◽  
Seong Ho Choi ◽  
Dong Wook Choi ◽  
...  
Keyword(s):  
Distal Pancreatectomy ◽  
Neuroendocrine Tumors ◽  
Pancreatic Neuroendocrine Tumors ◽  
Single Center ◽  
Open Distal Pancreatectomy ◽  
Single Center Study ◽  
Center Study

Best prognostic factor of neuroendocrine tumors: Grade or Stage? A multidisciplinary single-center study

2016 ◽  
Vol 27 (6) ◽  
pp. 509-514 ◽  
Author(s):  
Ersin Ozaslan ◽  
Fahri Bayram ◽  
Halit Karaca ◽  
Sebnem Gursoy ◽  
Figen Ozturk ◽  
...  
Keyword(s):  
Prognostic Factor ◽  
Neuroendocrine Tumors ◽  
Single Center ◽  
Single Center Study ◽  
Center Study

scholarly journals Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study

2020 ◽  
Vol 61 (8) ◽  
pp. 1153-1160 ◽  
Author(s):  
Ida Sonni ◽  
Matthias Eiber ◽  
Wolfgang P. Fendler ◽  
Rejah M. Alano ◽  
Sitaram S. Vangala ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Patients ◽  
Clinical Settings ◽  
Single Center ◽  
Pet Ct ◽  
Single Center Study ◽  
Center Study

scholarly journals Concomitant lung and gastroenteropancreatic neuroendocrine tumors and the value of gallium-68 PET/CT

2011 ◽  
Vol 11 (1) ◽  
pp. 179-183 ◽  
Author(s):  
Daniel Kaemmerer ◽  
Karl Khatib-Chahidi ◽  
Richard Paul Baum ◽  
Dieter Horsch ◽  
Norbert Presselt ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Gastroenteropancreatic Neuroendocrine Tumors ◽  
Pet Ct ◽  
Gallium 68

scholarly journals Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study

BMC Cancer ◽  
2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Maarten L. Donswijk ◽  
Pim J. van Leeuwen ◽  
Erik Vegt ◽  
Zing Cheung ◽  
Stijn W. T. P. J. Heijmink ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Impact ◽  
Single Center ◽  
Primary Prostate Cancer ◽  
Psma Pet ◽  
Pet Ct ◽  
Single Center Study ◽  
Center Study

Diagnostic performance of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for the evaluation of hypermetabolic lymphadenopathy mediastinum lower, posterior, and middle, detected by PET-CT with 18F-FDG (PET) (APOGEE Study).

2020 ◽  
Vol 38 (4_suppl) ◽  
pp. 798-798
Author(s):  
Dominique Bechade ◽  
Carine A. Bellera ◽  
Coralie Cantarel ◽  
Isabelle Soubeyran ◽  
Marc Debled ◽  
...  
Keyword(s):  
Lymph Nodes ◽  
Diagnostic Performance ◽  
Therapeutic Strategy ◽  
Mediastinal Lymphadenopathy ◽  
Single Center ◽  
Diagnostic Certainty ◽  
Pet Ct ◽  
Single Center Study ◽  
18F Fdg ◽  
Center Study

798 Background: In the context of a new cancer or relapse, the high sensitivity (Se) (95-100%) of PET-CT with 18F-FDG can lead to the demonstration of hypermetabolic mediastinal adenopathies. Its lower specificity (Sp) (89%) can require histological examination. We report the results of a prospective, single-center study evaluating the diagnostic performance of EUS-FNA in this indication. Methods: Prospective single-center study featuring patients in whom PET had revealed hypermetabolic mediastinal lymphadenopathy requiring diagnostic certainty. All EUS-FNA were performed with a 19-gauge needle (EchoTip, Cook Endoscopy). Main objective: To evaluate the diagnostic performance in terms of Se and Sp of EUS-FNA in the characterization of hypermetabolic mediastinal adenopathies in PET in the context of a new cancer or relapse. Secondary objectives: To evaluate the negative predictive value (NPV) of the EUS-FNA and to evaluate the percentage of surgical diagnostic procedures avoided. The standard technique was a thoraco-abdominopelvic CT scan at 6 months and at 12 months. Results: 52 patients were eligible and evaluable for the primary endpoint. The most common primary cancers were mammary (17.3%) and bronchial (13.5%). The lymph nodes were analyzed as malignant in 44.2% of cases, benign in 50% of cases and atypical or suspicious in 3.8% of cases. The malignant lymph nodes were metastatic for breast cancer in 21.7% of cases, bronchial cancer in 17.4% of cases, colorectal cancer in 17.4% of cases and prostate cancer in 13% of cases. The Se of the EUS-FNA was 92% (95% CI 0.74-0.99) and the Sp 100%. NPV was 87% (95% CI: 0.59-0.98). A diagnostic surgical procedure was necessary in 2% of the cases. PET and EUS-FNA often allowed the modification of the therapeutic strategy. Conclusions: When a confirmed diagnosis is required, the diagnostic accuracy of the minimally invasive procedure of EUS-FNA, is sufficiently robust to avoid a surgical diagnosis technique. The combination of PET and EUS-FNA may alter the therapeutic strategy that would have been considered after PET alone. Clinical trial information: NCT01892501.

Sign in / Sign up

Export Citation Format

Share Document